Summary of Study ST000898

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000624. The data can be accessed directly via it's Project DOI: 10.21228/M8109M This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST000898
Study TitleTAp73 is a marker of glutamine addiction in medulloblastoma
Study TypesiRNA constructs targeting p73 (ID: 2671-AMBION) and a non-targeting control siRNA (scramble) were transfected with 10 pM siRNA with lipofectamine 3000 according to the supplier’s protocol for 48 hours
Study SummaryMetabolically-targeted therapies hold the promise of offering an effective and less toxic treatment for tumours including medulloblastoma, the most common malignant brain tumour of childhood. Current treatment relies on the sensitivity of these tumours to DNA damage that was discovered more than 50 years ago. Finding new tumour-specific susceptibilities to complement sensitivity to DNA damage is key to developing new more effective adjuvant therapies. The specific metabolic program of tumours is an attractive vulnerability, as restriction diet are low cost and easy to implement. Here, we present compelling pre-clinical evidence that glutamine restriction diet can be used as an adjuvant treatment for p73-expressing medulloblastoma.
Institute
Queen Mary University of London
DepartmentBlizard Institute
LaboratoryCentre for Genomics and Child Health
Last NameMarino
First NameSilvia
Address4 Newark Street, E1 2AT, London
Emails.marino@qmul.ac.uk
Phone+44 20 7882 2360
Submit Date2017-08-24
Num Groups2
Total Subjects18
Study CommentsWe include 3 biological replicate with 3 technical replicates for each condition.
Raw Data AvailableYes
Analysis Type DetailLC-MS
Release Date2017-11-20
Release Version1
Silvia Marino Silvia Marino
https://dx.doi.org/10.21228/M8109M
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Sample Preparation:

Sampleprep ID:SP000942
Sampleprep Summary:The samples were thawed at room temperature and subjected to centrifugation for 17 min at 3000 rpm and 4°C. A quality control (QC) sample was created by pooling an equal volume from all samples. The aqueous supernatants were transferred to clean extraction tubes followed by addition of chloroform and methanol for the final proportion 2.85:4:4 water:methanol:chloroform. The extraction tubes were gently vortexed and then stored at 8°C for 20 min prior to centrifugation for 20 min at 3000 rpm and 4°C. The aqueous phases were recovered and evaporated to dryness at 40°C under N2. All samples were stored at -80°C after evaporation. Prior to analysis the samples were reconstituted in acetonitrile:Milli-Q water 90:10
Processing Method:lysis, freeze thaw cycles and sonication (see cell harvesting)
Processing Storage Conditions:Room temperature and 8°C during extraction, -80°C before and after extraction
Extraction Method:Liquid Liquid Extraction using CHCl3:MeOH:H2O 4:4:2.85
Extract Storage:Extracts were stored in -80°C after evaporation
Sample Resuspension:Acetonitrile:Milli-Q water 90:10
Cell Type:Daoy cells
  logo